AbCellera Biologics Inc (ABCL) has gained 1.65% Monday In Premarket Trading

AbCellera Biologics Inc (ABCL) is up Monday morning, with the stock increasing 1.65% in pre-market trading to 21.5. ABCL's short-term technical score of 2 indicates that the stock has traded less bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 137 out of 146 industries, AbCellera Biologics Inc ranks higher than 3% of stocks. AbCellera Biologics Inc has risen 20.31% over the past month, closing at $17.35 on August 30. During this period of time, the stock fell as low as $16.78 and as high as $22.63. ABCL has an average analyst recommendation of Strong Buy. The company has an average price target of $45.25.

ABCL has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on ABCL!

See Full ABCL Report

AbCellera Biologics Inc has a Long-Term Technical rank of 0. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 100% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, ABCL ranks better than 0% of stocks.

Important Dates for Investors in ABCL:

-AbCellera Biologics Inc is set to release earnings on 11/10/2021. During their last earnings release the company posted EPS of $0.79. -We do not have a set dividend date for AbCellera Biologics Inc at this time. Click Here To Get The Full Report on AbCellera Biologics Inc (ABCL)